Nanoparticle albumin bound™(nab™) technology is an established delivery platform for
development of albumin stabilized nanoparticles as drug delivery systems for poorly water …

Protein/antibody therapeutics have exhibited the advantages of high specificity and activity
even at an extremely low concentration compared to small molecule drugs. However, they …

Recent advances in biotechnology demonstrate that peptides and proteins are the basis of a
new generation of drugs. However, the transportation of protein drugs in the body is limited …

The development of clinically acceptable albumin-based nanoparticle formulations for use in
pulmonary drug delivery has been hindered by concerns about the toxicity of nanomaterials …

Aim: A Nano-in-Nano approach was exploited to facilitate incorporation of the
chemotherapeutic drug etoposide (ETP) as nanosuspension, synergistically with berberine …

In recent decades, scientific and medical communities have continuously sought new
methods and chemistries to improve the treatment of cancer. Among many types of …

There is a need of a carrier that can deliver drugs to the targeted cells and organs, where it
can prolong and localize its effect, interacting with the diseased part of the organ specifically …

One of the most challenging tasks for formulators in the pharmaceutical industry is the
formulation of poorly soluble drugs. Conventional techniques employed for improving …

Current cancer therapies are challenged by weakly soluble drugs and by drug combinations
that exhibit non‐uniform biodistribution and poor bioavailability. In this study, we have …

Traditional drugs are facing bottlenecks of lower solubility, absorption, and especially the
inefficient organs or cells targeting during the precision medicine era. It is urgently needed to …